home / stock / vstm / vstm articles
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 50 points on Friday. Following the market opening Friday, the Dow t...
Thursday, Verastem Oncology (NASDAQ:VSTM) announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 t...
Shares of Ross Stores, Inc. (NASDAQ:ROST) rose sharply in today's pre-market trading after the company reported better-than-expected earnings ...
Over the past twenty days of trading, Verastem Inc. (NASDAQ: VSTM), from May 18, 2023 to June 15, 2023 there is a potential Short Squeeze about to ...
News, Short Squeeze, Breakout and More Instantly...
GenFleet’s IND in China was cleared in June 2024; this is the first discovery program from the collaboration Verastem announced in 2023 to advance into human clinical trials Verastem plans to initiate development studies outside of China after evaluating initial dose escalation dat...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that in connection with the 2024 Russell U.S. Indexes annual reconstitution, the company will be added to the Russell 3000 ® and Russell Microcap ...
2024-06-12 09:44:18 ET USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 12, 2024 – USA News Group – After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovere...